In this study, we explored the efficacy of combining IL-10 and the oncolytic Ad-hTERT viroimmunotherapy in Lewis lung carcinoma (LLC) and B16F10-bearing C57BL/6 mice and found that the combination therapy demonstrated a profound antitumor effect. This evidence concerns the gene IL10 and Carcinoma, Lewis Lung.